2025 Market Access Guide for Biotech: What is essential and what is a waste of resources
In the competitive and resource-constrained world of biotechnology, achieving market access and reimbursement is critical.
In the competitive and resource-constrained world of biotechnology, achieving market access and reimbursement is critical.
The implementation of the Joint Clinical Assessment (JCA) in the European Union represents a notable
On July 4, 2024, the Bundestag (German Parliament) passed significant amendments to the country’s drug
What you need to know about confidential discounts and net prices in EU-5 In the
The new Joint Clinical Assessment (JCA) and Joint Scientific Consultation (JSC) initiatives, which are part
The Inflation Reduction Act (IRA), signed into law in August 2022, is a piece of
Justin Stindt Consultants is a fast growing consulting company offering strategy & market access consulting services to leading pharmaceutical, biotech and medical device clients. We operate in Europe and the United States.
